Medical Care Technologies Inc.
MDCEdata completeness 75%2 fiscal years on fileData notes: no data for concept 'revenue'; no data for concept 'totalDebt'; no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'; no data for concept 'incomeTaxExpense'
| Figure | FY 2010 | FY 2011 |
|---|---|---|
| Revenue | — | — |
| Net income | −$2.19M1 | −$1.92M1 |
| Operating cash flow | −$189,9352 | −$371,9202 |
| Capital expenditure | $03 | $6,2003 |
| Free cash flow (derived) | −$189,9352 | −$378,1202 |
| Total debt | — | — |
| Cash & equivalents | $3914 | $3,3804 |
| Diluted shares | 161.0M | 308.9M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$0.01 of net worth that earned you −$0.06 and generated −$0.01 of cash last year.
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Share count is up 92% over 2 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2010-12-31 · accession 0001213900-12-001816 (NetIncomeLoss)
- 10-K · period ending 2010-12-31 · accession 0001213900-12-001816 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2010-12-31 · accession 0001213900-12-001816 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2010-12-31 · accession 0001213900-12-001816 (CashAndCashEquivalentsAtCarryingValue)